Last reviewed · How we verify
Talcum powder
At a glance
| Generic name | Talcum powder |
|---|---|
| Also known as | Talc |
| Sponsor | Center Trials & Treatment Europe |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Talc Slurry Versus Talc Insufflation: A Study on Effectiveness, Safety, and Hospital Outcomes in Pleurodesis (NA)
- Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study (NA)
- Open-Label Placebo Treatment of Women With Premenstrual Syndrome (NA)
- Evaluation of the Efficacy of Compression With Tight Surgical Gloves in Patients With Taxane-based Therapy (NA)
- Conditioned Open-label Placebos to Facilitate Opioid Reduction in Patients With Chronic Non-cancer Pain (NA)
- Stop Air Leak by Talc or Autologous Blood Patch Therapy (PHASE2, PHASE3)
- Tryptophan for Impaired AhR Signaling in Celiac Disease (NA)
- Extracts of Amla, Walnut Leaf, Red Yeast Rice and Olive in Cardiovascular Prevention (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Talcum powder CI brief — competitive landscape report
- Talcum powder updates RSS · CI watch RSS
- Center Trials & Treatment Europe portfolio CI